To learn more about Azstarys, see this Azstarys overview. Your doctor likely will start your treatment with an Azstarys dosage of 39.2 mg/7.8 mg once per day. They may increase the dosage after 1 ...

As a result, ivermectin exposure in children following a 200 µg/kg dose is ∼30% lower than in adults. An increased dose of 250 and 300 µg/kg would be needed in school-aged children (6–12 years) and ...

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone ... patients treated with Spravato should receive a dose ...

The maximum daily bupropion SR dosage for depression is 400 mg (200 mg taken twice per day). Bupropion XL: The typical starting dosage of bupropion XL for treating depression is 150 mg once per day.

McIntyre said. “We have not seen that.” Research also suggests that esketamine nasal spray doesn’t affect thinking skills the way high doses of ketamine do. What’s Next Along with ...

At launch, the Flexus Core 200 sat at the top of Klipsch’s soundbar range, though a step-up model has since been announced. It’s off to a solid start, especially from a specification perspective. The ...

By Keith Caulfield Bad Bunny’s Debí Tirar Más Fotos captures a second week at No. 1 on the Billboard 200 albums chart (dated Feb. 1), earning 151,000 equivalent album units in the U.S. in the ...

Update: Sony has gone some way towards addressing the main issue with its first-generation 70-200mm f/2.8 lens in the form of its successor: the FE 70-200 f/2.8 GM II. This updated version is a full ...

Copyright 2025 The Associated Press. All Rights Reserved. In this undated photo provided by the South Carolina Department of Corrections, viewing chairs are placed in ...

The nasal spray Spravato, which is made from the drug ... particularly those who haven't responded to previous doses of traditional antidepressants.

The study consists of two parts, a dose escalation part, with the first patient enrolled in China recently, and a dose selection optimization part which will be initiated after part 1 is completed.